Litifilimab

5 trials 2 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

1 Sponsors

15 Countries

Phase III

Phase II/III

Phase III: 4 Phase II/III: 1

Indications tested

Systemic lupus erythematosus 3 Chronic cutaneous lupus erythematosus 2 Subacute cutaneous lupus erythematosus 2 Cutaneous lupus erythematosus 2

Sponsors using this IMP

Biogen Idec Research Limited 5

All trials

5 total

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adul… Recruiting

2023-504863-17-00 Phase III 11 countries Biogen Idec Research Limited
A Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cut… Recruiting

2023-505634-94-00 Phase II/III 11 countries Biogen Idec Research Limited
A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD) Ended

2023-505635-13-00 Phase III 13 countries Biogen Idec Research Limited
A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background N… Ended

2023-505696-74-00 Phase III 7 countries Biogen Idec Research Limited
A Study to Evaluate the Efficacy and Safety of BIIB059 (Litifilimab) in Adult Participants With Active Systemic Lupus Erythematosus Receivin… Ended

2023-505695-30-00 Phase III 6 countries Biogen Idec Research Limited

Showing 1–5 of 5 trials

← All drugs A–Z